Health TrialsbyHealthPanel

HFCWO in Children With Non-CF Bronchiectasis

ConditionNon Cystic Fibrosis Bronchiectasis
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6-12
SponsorSphinx university

About this trial

the study will concentrate on the effect of High Frequency Chest Wall Oscillation compared to conventional pulmonary physiotherapy on children with non cystic fibrosis bronchiectasis

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

• Children with no cystic fibrosis bronchiectasis

Both sexes

Their ages ranges from 6-12 years

After 48 hours of attack, if hemoptysis or fever not found

Disqualifiers

• Osteoporosis (Calcium deficiency)

Bleeding tendency

Recent surgery of brain, eye, thoracic, or neck surgery

Pneumothorax

Trial design

Design model

Parallel

Treatments tested in this trial

  • High Frequency Chest Wall Oscillation

    Device

    High-frequency chest wall oscillation that applies external chest wall oscillations via an inflatable vest worn around the thoracic cage, increasing the air-liquid shear forces during expiration is believed to result in secretion mobilization. The product name that will be used is Air Way Clearness system; his model is PV-900/ PV-300/PV-100, made in China.

  • conventional physiotherapy program directed towards improvement of pulmonary functions and quality of life.

    Other intervention

    conventional physiotherapy program directed towards improvement of pulmonary functions and quality of life. Conventional physiotherapy that will be applied to the control group for 30 minutes will include: * Postural drainage according to accumulation of secretions for 10 minutes accompanied by percussion or vibration * Active cycle breathing technique (ACBT) for 10 minutes * Respiratory exercises for 10 minutes

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: children who will use HFCWO for 20 minutes, in addition to 10 minutes of the same conventional progrExperimental treatment 1 intervention
Group B: children who will be treated by conventional physiotherapy programActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Forced Expiratory Volume in 1 second (FEV1)

Change in FEV1 measured by spirometry according to ATS/ERS guidelines

Time frame
Baseline and after 8 weeks of treatment
2

Forced Vital Capacity (FVC)

Change in FVC measured by spirometry according to ATS/ERS guidelines

Time frame
Baseline and after 6 months of treatment
3

FEV1/FVC Ratio

Change in FEV1/FVC ratio measured by spirometry according to ATS/ERS guidelines

Time frame
Baseline and after 6 months of treatment

Secondary outcomes

1

Six-Minute Walk Distance (6MWD)

hange in functional exercise capacity assessed by the Six-Minute Walk Test (6MWT). The total distance walked in six minutes is recorded according to the American Thoracic Society (ATS) guidelines.

Time frame
Baseline and after 6 months of treatment

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Sphinx university

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: